Anthony Gerard Doyle

Person

Drummoyne, AU

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-PAR-2 antibodies and methods of use thereof
- Patent number 11,725,052
- Issue date Aug 15, 2023
- Cephalon LLC
- Anna Mikaela Bracken
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CXCR2 antibodies and uses thereof
- Patent number 11,332,534
- Issue date May 17, 2022
- Cephalon, Inc.
- Doris Shim Siew Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon alpha 2B variants
- Patent number 11,319,356
- Issue date May 3, 2022
- Teva Pharmaceuticals Australia Pty Ltd.
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies that specifically bind to human IL-15 and uses thereof
- Patent number 11,267,883
- Issue date Mar 8, 2022
- Cephalon, Inc.
- David Jose Simon Laine
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 11,253,591
- Issue date Feb 22, 2022
- Teva Pharmaceuticals Australia Pty Ltd.
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that specifically bind to TL1A and methods of treating r...
- Patent number 11,220,549
- Issue date Jan 11, 2022
- Cephalon, Inc.
- Lynn Dorothy Poulton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 11,117,975
- Issue date Sep 14, 2021
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-IL-5 antibodies
- Patent number 11,111,292
- Issue date Sep 7, 2021
- Cephalon, Inc.
- Mark Terence Liddament
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusions of antibodies to CD38 and attenuated interferon alpha
- Patent number 10,981,986
- Issue date Apr 20, 2021
- Teva Pharmaceuticals Australia Pty Ltd.
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against TL1a and uses thereof
- Patent number 10,822,422
- Issue date Nov 3, 2020
- Teva Pharmaceuticals Australia Pty Ltd.
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon alpha 2B variants
- Patent number 10,544,199
- Issue date Jan 28, 2020
- Teva Pharmaceuticals Australia Pty Ltd.
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 10,232,041
- Issue date Mar 19, 2019
- TEVA PHARMACEUTICALS PTY LTD
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies that specifically bind to TL1A
- Patent number 10,138,296
- Issue date Nov 27, 2018
- Cephalon, Inc.
- Lynn Dorothy Poulton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 9,963,515
- Issue date May 8, 2018
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 9,636,334
- Issue date May 2, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusions of antibodies to CD38 and attenuated interferon alpha
- Patent number 9,611,322
- Issue date Apr 4, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-IL-23 heterodimer specific antibodies
- Patent number 9,127,057
- Issue date Sep 8, 2015
- Teva Pharmaceuticals Ausralia Pty Ltd
- Adam William Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer involving mutated KRAS or BRAF genes
- Patent number 8,932,588
- Issue date Jan 13, 2015
- Teva Pharmaceuticals Australia Pty Ltd
- Norbert A. Kienzle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies with anti-tumor activity
- Patent number 8,901,279
- Issue date Dec 2, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- Adam W. Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-IL-12/IL-23 antibodies
- Patent number 8,563,697
- Issue date Oct 22, 2013
- Cephalon Australia Pty Ltd
- Adam William Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanised antibodies with anti-tumour activity
- Patent number 8,470,320
- Issue date Jun 25, 2013
- Cephalon Australia Pty Ltd.
- Adam W. Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-inflammatory dAb
- Patent number 8,263,076
- Issue date Sep 11, 2012
- Cephalon Australia Pty Ltd.
- Benjamin P. Woolven
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-inflammatory dAb
- Patent number 7,981,414
- Issue date Jul 19, 2011
- Cephalon Australia Pty Ltd
- Benjamin P. Woolven
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Domain antibody construct
- Patent number 7,846,439
- Issue date Dec 7, 2010
- Cephalon Australia Pty Ltd
- Anthony G. Doyle
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20240150457
- Publication date May 9, 2024
- Cephalon LLC
- Anna Mikaela BRACKEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST TL1A AND USES THEREOF
- Publication number 20240141053
- Publication date May 2, 2024
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy POULTON
- G01 - MEASURING TESTING
Information Patent Application
ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATES AND USES THEREOF
- Publication number 20240076343
- Publication date Mar 7, 2024
- Cephalon LLC
- David S. WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR ANTI-PACAP ANTIBODIES
- Publication number 20230212281
- Publication date Jul 6, 2023
- Cephalon, LLC
- Anthony Gerard DOYLE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CXCR2 ANTIBODIES AND USES THEREOF
- Publication number 20220348671
- Publication date Nov 3, 2022
- Cephalon, Inc.
- Doris Shim Siew Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20220220184
- Publication date Jul 14, 2022
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies That Specifically Bind To TL1A
- Publication number 20220185902
- Publication date Jun 16, 2022
- Cephalon, Inc.
- Lynn Dorothy POULTON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF
- Publication number 20220127352
- Publication date Apr 28, 2022
- Cephalon, Inc.
- David Jose Simon LAINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220056125
- Publication date Feb 24, 2022
- Cephalon, Inc.
- Anna Mikaela BRACKEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-IL-5 Antibodies
- Publication number 20210355205
- Publication date Nov 18, 2021
- Cephalon, Inc.
- Mark Terence Liddament
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST TL1A AND USES THEREOF
- Publication number 20210347904
- Publication date Nov 11, 2021
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy POULTON
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF
- Publication number 20200270339
- Publication date Aug 27, 2020
- Cephalon, Inc.
- David Jose Simon LAINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20200102364
- Publication date Apr 2, 2020
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CXCR2 ANTIBODIES AND USES THEREOF
- Publication number 20200040089
- Publication date Feb 6, 2020
- CEPHALON, INC.
- Doris Shim Siew Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...
- Publication number 20190151447
- Publication date May 23, 2019
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies That Specifically Bind To TL1A
- Publication number 20190106486
- Publication date Apr 11, 2019
- Cephalon, Inc.
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20180305460
- Publication date Oct 25, 2018
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-IL-5 Antibodies
- Publication number 20180186873
- Publication date Jul 5, 2018
- Cephalon, Inc.
- Mark Terence Liddament
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSIONS OF ANTIBODIES TO CD38 AND ATTENUATED INTERFERON ALPHA
- Publication number 20170233449
- Publication date Aug 17, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...
- Publication number 20170202962
- Publication date Jul 20, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES THAT SPECIFICALLY BIND TO TL1A
- Publication number 20170081400
- Publication date Mar 23, 2017
- Cephalon, Inc.
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDE CONSTRUCTS AND USES THEREOF
- Publication number 20160367695
- Publication date Dec 22, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Against TL1a and Uses Thereof
- Publication number 20160333104
- Publication date Nov 17, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy Poulton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL-12/IL-23 ANTIBODIES
- Publication number 20160264661
- Publication date Sep 15, 2016
- Adam William Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20160122410
- Publication date May 5, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20160068612
- Publication date Mar 10, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of Lenalidomide and Polypeptide Construct, and Uses The...
- Publication number 20150313965
- Publication date Nov 5, 2015
- Teva Pharmaceuticals Australia Pty, Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CD1d
- Publication number 20140286957
- Publication date Sep 25, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- Jonathan Kannan Nambiar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST TL1a AND USES THEREOF
- Publication number 20140255302
- Publication date Sep 11, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- Lynn Dorothy Poulton
- G01 - MEASURING TESTING
Information Patent Application
POLYPEPTIDE CONSTRUCTS AND USES THEREOF
- Publication number 20140248238
- Publication date Sep 4, 2014
- Teva Pharmaceuticals Australia Pty Ltd
- David S. Wilson
- C07 - ORGANIC CHEMISTRY

Anthony Gerard Doyle

Person

Patents Grantslast 30 patents

Anti-PAR-2 antibodies and methods of use thereof

Anti-CXCR2 antibodies and uses thereof

Interferon alpha 2B variants

Antibodies that specifically bind to human IL-15 and uses thereof

Combination of lenalidomide and polypeptide construct, and uses the...

Antibodies that specifically bind to TL1A and methods of treating r...

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Anti-IL-5 antibodies

Fusions of antibodies to CD38 and attenuated interferon alpha

Antibodies against TL1a and uses thereof

Interferon alpha 2B variants

Combination of lenalidomide and polypeptide construct, and uses the...

Antibodies that specifically bind to TL1A

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Combination of lenalidomide and polypeptide construct, and uses the...

Fusions of antibodies to CD38 and attenuated interferon alpha

Anti-IL-23 heterodimer specific antibodies

Treatment of cancer involving mutated KRAS or BRAF genes

Humanized antibodies with anti-tumor activity

Anti-IL-12/IL-23 antibodies

Humanised antibodies with anti-tumour activity

Anti-inflammatory dAb

Anti-inflammatory dAb

Domain antibody construct

Patents Applicationslast 30 patents

ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES AGAINST TL1A AND USES THEREOF

ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATES AND USES THEREOF

COMPOSITIONS AND METHODS FOR ANTI-PACAP ANTIBODIES

ANTI-CXCR2 ANTIBODIES AND USES THEREOF

INTERFERON ALPHA 2B VARIANTS

Antibodies That Specifically Bind To TL1A

ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF

ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF

Anti-IL-5 Antibodies

ANTIBODIES AGAINST TL1A AND USES THEREOF

ANTIBODIES THAT SPECIFICALLY BIND TO HUMAN IL-15 AND USES THEREOF

INTERFERON ALPHA 2B VARIANTS

ANTI-CXCR2 ANTIBODIES AND USES THEREOF

COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...

Antibodies That Specifically Bind To TL1A

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

Anti-IL-5 Antibodies

FUSIONS OF ANTIBODIES TO CD38 AND ATTENUATED INTERFERON ALPHA

COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...

ANTIBODIES THAT SPECIFICALLY BIND TO TL1A

POLYPEPTIDE CONSTRUCTS AND USES THEREOF

Antibodies Against TL1a and Uses Thereof

ANTI-IL-12/IL-23 ANTIBODIES

INTERFERON ALPHA 2B VARIANTS

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

Combination of Lenalidomide and Polypeptide Construct, and Uses The...

ANTIBODIES TO CD1d

ANTIBODIES AGAINST TL1a AND USES THEREOF

POLYPEPTIDE CONSTRUCTS AND USES THEREOF